IVIg vs placebo
The review found no eligible studies for this question.
- no estimate extractedStudies not reportedNo studies found
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Intravenous immunoglobulin may leads to higher response at 3 months compared with placebo (low certainty).
Intravenous immunoglobulin showed no clear difference in relapse at 3 months compared with placebo (low certainty).
Intravenous immunoglobulin may leads to higher adverse events compared with placebo (low certainty).
The review found no eligible studies for this question.
The intervention may leads to higher sustained remission (low certainty).
The review found no eligible studies for this question.
The intervention showed no clear difference in total number of adverse events (low certainty).
The intervention may leads to higher serious infections (low certainty).
Pulse cyclophosphamide showed no clear difference in death at final compared with continuous cyclophosphamide (low certainty).
Mohs micrographic surgery showed no clear difference in recurrence at 3 years compared with surgical excision (low certainty).
The review found no eligible studies for this question.
Radiotherapy may leads to higher recurrence at 3 years compared with surgical excision (with or without frozen section margin control) (low certainty).
Radiotherapy probably leads to lower cosmetic outcome (good/excellent) compared with surgical excision (with or without frozen section margin control) (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
MAL‐PDT may leads to higher recurrence at 3 years compared with surgical excision (low certainty).
MAL‐PDT probably leads to higher cosmetic outcome (excellent/good) compared with surgical excision (moderate certainty).